Not applicableStudy completedNCT04355702What this trial is testingCovid-19 in Lupus PatientsWho this might be right forSystemic Lupus ErythematosusCovid-19 University Hospital, Montpellier 130
Testing effectiveness (Phase 2)Ended earlyNCT02102594What this trial is testingTherapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)Who this might be right forMyasthenia GravisSystemic Lupus ErythematosusRheumatoid Arthritis Charite University, Berlin, Germany 11
Not applicableStudy completedNCT02217137What this trial is testingTear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus PatientsWho this might be right forDry Eye Singapore National Eye Centre 80
Not applicableUnknownNCT06379646What this trial is testingAn Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseWho this might be right forSystemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Large-scale testing (Phase 3)Study completedNCT00004662What this trial is testingPhase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus National Center for Research Resources (NCRR) 300
Testing effectiveness (Phase 2)Study completedNCT02756546What this trial is testingCirculating MicroRNAs in Understanding Pathogenesis of Systemic Lupus ErythematosisWho this might be right forSystemic Lupus Erythematosis Cairo University 100
Early research (Phase 1)Ended earlyNCT04700267What this trial is testingA Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Lakefront Biotherapeutics NV 11
Early research (Phase 1)Study completedNCT02194400What this trial is testingDose Escalation Study of RSLV-132 in Subjects With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Resolve Therapeutics 32
Testing effectiveness (Phase 2)Study completedNCT05433857What this trial is testingProbiotics in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Ain Shams University 40
Not applicableUnknownNCT05613582What this trial is testingThe Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusChronic Headache Universitas Indonesia 88
Not applicableStudy completedNCT07048470What this trial is testingEfficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus PatientsWho this might be right forSystemic Lupus Erythematosus Universitas Sriwijaya 36
Not applicableLooking for participantsNCT05127980What this trial is testingOccurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV InfectionWho this might be right forEpstein-Barr Virus (EBV) Infection University Hospital, Basel, Switzerland 80
Not applicableLooking for participantsNCT07397728What this trial is testing" TREX1 Gene Mutations and Their Role in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus South Valley University 90
Early research (Phase 1)Study completedNCT06064929What this trial is testingLearn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years OldWho this might be right forLupus Nephritis HI-Bio, A Biogen Company 14
Large-scale testing (Phase 3)WithdrawnNCT00382837What this trial is testingStudy of Epratuzumab in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus UCB Pharma
Early research (Phase 1)Looking for participantsNCT06801119What this trial is testingEfficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）Who this might be right forSystemic Lupus ErythematosusSclerodermaRheumatoid Arthritis Shenzhen MagicRNA Biotechnology Co., Ltd 30
Early research (Phase 1)Study completedNCT01687309What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and GenderWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 19
Post-approval studies (Phase 4)Study completedNCT04515719What this trial is testingEfficacy and Safety of Belimumab in SLE PatientsWho this might be right forSystemic Lupus Erythematosus RenJi Hospital 231
Testing effectiveness (Phase 2)Study completedNCT04058028What this trial is testingEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus (SLE) Amgen 244
Not applicableStudy completedNCT06046534What this trial is testingRetrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.Who this might be right forSystemic Lupus Erythematosus AstraZeneca 46